http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2214602-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5aa747b916f3611c552e84d97114032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8c18bd94106371c0396ff776e804901
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067
filingDate 2002-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2003-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8696207befeca650b1e5ecdf3d570827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00abb7118ee64de0c68abe3b191028d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_335bf6ac88945b866d8d5703b56cac43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2263c90f8ed81b354154f0523f4aae9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4712ecc82f8c00f3ec9de09f0708678c
publicationDate 2003-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2214602-C1
titleOfInvention Method for predicting addition of inflammatory complications in acute period of cranial trauma and method for their prophylaxis
abstract FIELD: medicine, neurosurgery, neurology, immunology. SUBSTANCE: one should detect the value of humoral blood response taking into consideration the presence of functional asymmetry syndrome in immune response at dextro- and levohemispheral localization of lesion foci. Moreover, one should additionally detect the value of patient's humoral liquor response, also, taking into account the presence of functional asymmetry syndrome in immune response at dextro- and levohemispheral localization of lesion foci, moreover, as value of humoral response of blood and liquor one should apply cytokinic response of proinflammatory interleukin- 1beta and addition of inflammatory complication at dextro-and levohemispheral localization of lesion foci is predicted since 1st till 14th d after the onset of cranial trauma at the following values of this parameter in blood and liquor, at dextrohemispheral localization of lesion focus: in blood: above 350pg/ml, and, also, below 150 pg/ml during 1st-3d d, above 150 pg/ml during 4th-7th d and above 62 pg/ml during 8th-14th d; in liquor: above 80 pg/ml, and, also, below 30 pg/ml during 1st-3d d, above 71 pg/ml during 4th-7th d and at no normalization of its values to the end of 8th-14th d, and at levohemispheral localization of lesion focus: in blood: above 200 pg/ml, and, also, below 40 pg/ml during 1st-3d d, above 240 pg/ml during 4th-7th d and above 120 pg/ml during 8th-14th d; in liquor: above 17 pg/ml, and, also, below 5 pg/ml during 1st-3d d, above 48 pg/ml during 4th- 7th d and at no normalization of its values to the end of 8th- 14th d. For prophylaxis of addition of inflammatory complications in acute period of cranial trauma it is necessary to conduct immunocorrecting therapy according to the results of prediction for addition of inflammatory complications in acute period of cranial trauma, moreover, it is carried out since 4th-14th d after cranial trauma appeared at all the values of parameter tested at predicting addition of inflammatory complications in acute period of cranial trauma - proinflammatory interleukin-1beta - in blood and liquor, except values during 1st-3d d after the onset of cranial trauma for dextrohemispheral localization of lesion focus - in blood - above 350 pg/ml and in liquor - above 80 pg/ml, and for levohemispheral localization of lesion focus - in blood - above 200 pg/ml and in liquor - above 17 pg/ml, moreover, patient is injected with immunostimulating preparation -betaleukin (recombinant IL-1beta) daily for 7 d per 5 ng/kg yield of antiphlogistic cytokin as interleukin-1beta or contactly affected with immunomodeling low-intensity laser radiation at 0.89 mcm wave length onto carotid and vertebral arteries from both sides, onto projections of right and left adrenal glands, ethmoid bone and mastoid process from the side of lesion, at the following modes of impact: onto carotid arteries - daily for 10 d per 1-3 min/each one at radiation at 1500- 3000 Hz impulse frequency and impulse power of 5-10 W; onto vertebral arteries - daily, for 10 d per 5-3 min/each one at radiation at impulse frequency of 80-150 Hz and impulse power of 5-10 W; onto projections of right and left adrenal glands - daily, for 5-7 d per 1-2 min/each, at radiation at impulse frequency of 80-150 Hz and impulse power of 3-7 W; onto projection of ethmoid bone - daily, for 5-7 d per 5 min at impulse frequency of 1500- 3000 Hz and impulse power of 3-7 W, onto projection of mastoid process - daily, for 5-7 d per 3-5 min at impulse frequency of 1500-3000 Hz and impulse power of 3-7 W. EFFECT: higher accuracy of prediction. 2 cl, 10 ex, 2 tbl _
priorityDate 2002-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492817
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP46648
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCH0YYU7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE2R865
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26889
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2HZH0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD4A1A6
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID450200
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE2R8Z2
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16176
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395196
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD4A9I5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100136024
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE1BD32
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51745
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9XS77
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01584
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8WNR2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41687
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24494
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100052414
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ28292
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9793
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48090
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6X1Q9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403974
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6PUD2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE1BLE5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID405770
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA4UYK8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCJ9NSP1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCJ9P745
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281251
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9YGD3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP14628
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1MKE9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1MWT5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3553
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A0R4IYF1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP79162
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2MH07
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP79182
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ63264
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9793
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6R2X3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21621
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ865X8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO73909
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100034237
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ28386
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9WVG1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PT49

Total number of triples: 73.